Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
about
Innate immune targets of hepatitis B virus infectionPrevention and Treatment of Recurrent Hepatitis B after Liver TransplantationAdaptive immunity in the liverCrosstalk between innate and adaptive immunity in hepatitis B virus infectionThe Role of Immune Cells in Chronic HBV InfectionProgrammed death-1/programmed death-L1 signaling pathway and its blockade in hepatitis C virus immunotherapyMolecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceTherapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuckDeveloping Combined HIV Vaccine Strategies for a Functional CureThe immunological synapse: the gateway to the HIV reservoirHepatitis B: future curative strategiesHerpesvirus exploitation of host immune inhibitory pathwaysCurrent systemic treatment of hepatocellular carcinoma: A review of the literatureThe expression of PD-1 ligands and their involvement in regulation of T cell functions in acute and chronic woodchuck hepatitis virus infectionCapsid-Targeted Viral Inactivation: A Novel Tactic for Inhibiting Replication in Viral InfectionsFunctional Restoration of HCV-Specific CD8 T Cells by PD-1 Blockade Is Defined by PD-1 Expression and CompartmentalizationCostimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis CCurrent progress in the development of therapeutic vaccines for chronic hepatitis B virus infectionT-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significanceCurrent and future antiviral drug therapies of hepatitis B chronic infectionAcute Malaria Induces PD1+CTLA4+ Effector T Cells with Cell-Extrinsic Suppressor FunctionChronically inflamed livers up-regulate expression of inhibitory B7 family members.CD40 activation rescues antiviral CD8⁺ T cells from PD-1-mediated exhaustion.Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfectionHepatitis B Virus Immunopathology, Model Systems, and Current TherapiesInduction of IFN-γ cytokine response against hepatitis B surface antigen using melittin.In vitro and in vivo antivirus activity of an anti-programmed death-ligand 1 (PD-L1) rat-bovine chimeric antibody against bovine leukemia virus infection.Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustionNatural course of chronic hepatitis B is characterized by changing patterns of programmed death type-1 of CD8-positive T cells.Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies.Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets.Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients.CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibitionA tightly regulated IL-22 response maintains immune functions and homeostasis in systemic viral infection.Hurdles to the Development of Effective HBV Immunotherapies and HCV VaccinesAbsence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis.CD8+ Tregs in lupus, autoimmunity, and beyond.T-bet and Eomes are differentially linked to the exhausted phenotype of CD8+ T cells in HIV infection
P2860
Q26743647-436209EE-1C89-4869-96B0-6654F607A829Q26751777-D8957A85-3196-4035-851C-E6BAE233C5C1Q26753195-BEB03482-57C3-4CCA-8D47-BA3584816239Q26771142-A7687A9D-BEDF-4703-929B-4B93074BF84CQ26774875-3868975A-A49A-4D7B-9559-40EF633F644EQ26781481-BE8BF0D8-4928-4DF4-87D0-449B52EA380AQ26799246-73F1BD67-0A03-4E43-ADF4-66DC38357106Q26828598-5929767F-23A2-4B30-A461-A6D5A68CA2D2Q26998898-49366086-B852-4CF1-B208-C98797A0A726Q27002959-2DC68865-7C28-4C12-8C61-49B6E5301627Q27011623-F09F4DB1-4EAC-4D3A-B436-ADA2E78CB002Q27013680-24657858-64E7-40E8-8ECE-2BA6559827DFQ27026036-9B7CE122-DF04-4B26-90B5-346627143D5DQ27316653-3D0D82F0-CA0A-4F75-A3C9-FD0034B94B61Q27468669-FEDFC4E1-7315-49E1-828C-2C5E329F3C00Q27488289-E379219D-F621-4363-80DB-3AD766D87711Q27490355-1BB48161-D0AA-41F5-A32C-2AA14E5295D6Q28076279-E2D77B20-90E0-498E-984D-3103D93760D8Q28083810-B9614EB8-7C85-409E-AC5F-94C52871B337Q28084820-C485E04E-673C-4C04-AD26-237A39EE8407Q28109688-F425601E-F973-4486-9BD9-C4AE76E5C6D4Q30434304-15E4EA11-097C-44CE-AEBF-62B138E371C8Q31123164-84023450-7786-46BE-BED4-6361998F1711Q33449162-12EB83E0-947A-4436-B96A-DA7DA90D5199Q33559657-1BCB029E-C984-4ECF-9DAB-4ABA8F470F78Q33596807-87AF1C42-0220-48F6-A75C-2CC81F53911CQ33605673-7954728C-249A-4D50-89D6-09451A1ACBB5Q33614649-4641AF3D-75DE-48F8-B5E9-FEA188313B94Q33629455-E310E00B-E996-479B-8476-93CA7CD9A312Q33638083-8C5A169C-40CA-44AD-B86F-319DFBA9BE3BQ33671963-9B90B1CB-3AD9-4922-9A7E-5EF0F992C7C8Q33723810-3F14F845-142D-4BA2-8398-B092FF420BA0Q33731047-0C919927-D38E-4E28-8429-DFCB633413A7Q33734554-F0C308D1-ED87-4189-8B65-642E07E5E91FQ33762255-87B42DF4-E3DD-43CE-96A8-3970AB7CC4DAQ33818770-8AE5075C-7876-44C5-B9D9-5DAEE624A232Q33840260-50D16089-544E-4EC6-99A9-BAC67AE99B99Q33882896-48E27F4D-BFFB-40E4-AF2E-B5029BCB0D3CQ33889097-B820AC23-C9CE-417F-96E9-4A9440925131Q33916550-AE44F4D5-2E58-4C2E-B6B9-DDA466FDC786
P2860
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Characterization of hepatitis ...... ction in chronic HBV infection
@en
Characterization of hepatitis B virus
@nl
type
label
Characterization of hepatitis ...... ction in chronic HBV infection
@en
Characterization of hepatitis B virus
@nl
prefLabel
Characterization of hepatitis ...... ction in chronic HBV infection
@en
Characterization of hepatitis B virus
@nl
P2093
P2860
P50
P356
P1433
P1476
Characterization of hepatitis ...... ction in chronic HBV infection
@en
P2093
Albertina Cavalli
Barbara Amadei
Caterina Valdatta
Diletta Laccabue
Paola Di Vincenzo
Tiziana Giuberti
P2860
P304
P356
10.1128/JVI.02844-06
P407
P50
P577
2007-02-07T00:00:00Z